Summary
Engulfment of apoptotic cells by phagocytes is important throughout development and adult life [1, 2] . When phagocytes engulf apoptotic cells, they increase their cellular contents including cholesterol and phospholipids, but how the phagocytes respond to this increased load is poorly understood. Here, we identify one type of a phagocyte response, wherein the recognition of apoptotic cells triggers enhanced cholesterol efflux (to apolipoprotein A-I) from macrophages. Phosphatidylserine (PS) exposed on apoptotic cells was necessary and sufficient to stimulate the efflux response. A major mechanism for this enhanced efflux by macrophages was the upregulation of the mRNA and protein for ABCA1, a membrane transporter independently linked to cholesterol efflux as well as engulfment of apoptotic cells [3, 4] . This increase in phagocyte ABCA1 levels required the function of nuclear receptor LXRa/b, a known regulator of cholesterol homeostasis in humans and mice [5] . Taken together, these data reveal a ''homeostatic program'' initiated in phagocytes that include a proximal membrane signaling event initiated by PS recognition, a downstream signaling event acting through nuclear receptors, and an effector arm involving upregulation of ABCA1, in turn promoting reverse cholesterol transport from the phagocytes. These data also have implications for macrophage handling of contents derived from apoptotic versus necrotic cells in atherosclerotic lesions [6] .
Results and Discussion
Distribution of Apoptotic Cell-Derived Cholesterol within the Phagocyte We first addressed whether cholesterol derived from an engulfed apoptotic cell becomes distributed within the phagocyte or might be preferentially removed from the phagocyte. Fluorescent dansyl-cholesterol-labeled apoptotic Jurkat T lymphocytes were fed to J774 murine macrophage cells, and the distribution of dansylcholesterol within the phagocyte was monitored via fluorescence microscopy ( Figure 1A) . Engagement of the apoptotic corpse and its internalization by the J774 cells was complete by w30 min. Breakdown of the corpse began by 1 hr with distribution of the dansylcholesterol throughout the macrophage over the subsequent 8-10 hr. By 10 hr, dansyl-cholesterol was diffusely distributed throughout the macrophage. We also used 3 H-cholesterol-labeled apoptotic Jurkat cells to examine the distribution/efflux of apoptotic cell-derived cholesterol by the phagocyte. Again, we observed no preferential loss/efflux of the labeled apoptotic cellderived cholesterol by the J774 cells after engulfment (data not shown). Thus, the cholesterol derived from the apoptotic cells appeared to become part of the cholesterol pool of the phagocyte.
Stimulation of Enhanced Cholesterol Efflux from Macrophages by Apoptotic Cells
Since the uptake of apoptotic cell-derived cholesterol could potentially double the cholesterol content within the engulfing macrophage (or triple or quadruple the cholesterol content when macrophages take up multiple apoptotic cells [7] ), we asked whether the basal cholesterol efflux from the phagocyte might be enhanced as a possible homeostatic response to lower the cholesterol load. Cholesterol efflux can proceed through the ATP binding cassette (ABC) transporter ABCA1 via apolipoprotein A-I (apoA-I) as an acceptor, or through a nonspecific mechanism (possibly involving ABCG1) to highdensity lipoprotein (HDL). J774 cells were loaded with 3 H-cholesterol and then incubated with apoptotic Jurkat cells (denoted AJ). After the unengulfed AJ were washed away, HDL-or apoA-I-mediated cholesterol efflux was measured [8] . Addition of apoptotic Jurkat cells resulted in a reproducible increase in the basal cholesterol efflux to apoA-I (1.9-fold, p < 0.01, n = 8) ( Figure 1B ). In contrast, we observed no significant increase in cholesterol efflux to HDL (data not shown). In a time course of the efflux assay with apoA-I, the enhanced cholesterol efflux by the phagocyte was induced as early as 1-2 hr postincubation with apoptotic cells, peaked by about 4-6 hr ( Figure 1B ) and was similar to basal efflux by 10 hr (data not shown). This suggested that apoptotic cells induce a transient increase in the basal phagocyte cholesterol efflux to apoA-I. The percent efflux reported here is likely an underestimation of the efflux stimulated in the engulfing macrophages, since under these assay conditions only about 20% of the macrophages engulf the apoptotic cells but the efflux is measured over all the macrophages in the population. It is noteworthy that the percent efflux observed (w2%-15% in various experiments) is similar to that stimulated by agonists such as phorbol esters from macrophages in our hands [8] . This enhanced cholesterol efflux to apoA-I resulting from addition of apoptotic cells was not a unique property of J774 cells, and was seen in primary macrophages as well as fibroblasts (see below).
In contrast to apoptotic Jurkat cells, addition of necrotic Jurkat cells (denoted NJ) did not increase the basal cholesterol efflux from the J774 cells ( Figure 1C) . As assessed by microscopy, the necrotic Jurkat cells were taken up and the cholesterol derived from them distributed within the phagocyte (see Figure S1A in the Supplemental Data available online). We also tested apoptotic Jurkat cells that were coated with a CD3 antibody [7] , to allow Fc-receptor-mediated uptake. Interestingly, these antibody-coated apoptotic Jurkat cells failed to augment the basal cholesterol efflux ( Figure 1C ), although these targets were taken up and their cholesterol derived from them distributed within the phagocyte ( Figure S1B ). The lack of an increase in cholesterol efflux in phagocytes after incubation with necrotic cells or antibody-coated apoptotic cells was not due to a delayed kinetics of efflux ( Figure 1C ). We derived two important insights from the above data. First, apoptotic cells specifically induce a cholesterol efflux from phagocytes, whereas necrotic or opsonized corpses do not. Second, surprisingly, it is the route of entry of the apoptotic cells into macrophages (via engulfment receptors), rather than the simple increase in phagocyte total cholesterol content per se, that appears critical for stimulating an enhanced cholesterol efflux response from the phagocytes.
Surrogate Apoptotic Targets and Phosphatidylserine Vesicles Can Enhance Cholesterol Efflux from Macrophages
We next asked whether a surrogate apoptotic target that does not contain any cholesterol would also stimulate increased cholesterol efflux. We and others have previously used 2 mm carboxylate-modified polystyrene beads [9, 10] as an artificial target whose negative charge and other characteristics appear to mimic features on apoptotic cells (including blockage of their uptake by Annexin V and the requirement for specific signaling molecules within the phagocyte for their uptake). Remarkably, addition of these surrogate targets significantly enhanced cholesterol efflux from J774 cells (1.7-fold, p < 0.02, n = 8) (Figure 2A ). Consistent with the lack of CD3 on their cell surface, the cholesterol efflux induced by these beads was not inhibited by addition of CD3 antibodies (as with apoptotic Jurkat cells) ( Figure 2A) . Thus, the enhanced phagocyte cholesterol 3 H-cholesterol efflux from J774 cells was measured as above after incubation with apoptotic cells and Annexin V, anti-CD3-coated apoptotic Jurkat cells (to facilitate uptake via Fc receptor-mediated phagocytosis) or necrotic cells. Each experimental condition was performed in quadruplicate, and mean (6SD) from a representative experiment out of three independent experiments is shown. Asterisk indicates significant difference for the AJ condition compared to control. efflux appeared to be an early homeostatic response, stimulated only by recognition of apoptotic markers on targets, prior to the entry of the apoptotic cell-derived cholesterol.
PS-Dependent Stimulation of Cholesterol Efflux from Macrophages
While multiple ligands on apoptotic cells have been described, the exposure of phosphatidylserine (PS) on the outer leaflet of the plasma membrane of apoptotic cells (normally found on the inner side) is a key ''eat-me'' signal recognized by phagocytes [1, 2] . We tested the potential importance of recognizing PS on apoptotic cells for the induction increased cholesterol efflux from J774 cells. Addition of Annexin V to block the phagocyte recognition of PS on apoptotic Jurkat cells inhibited enhancement of cholesterol efflux in the J774 cells (Figure 1C) . To more directly test a role for PS, we added phosphatidylserine-containing microbubbles to J774 cells. Addition of 2 mm gas-filled PS bubbles (15% PS: 85% PC) stimulated cholesterol efflux from J774 cells (Figure 2A) . Similarly, PS-containing phospholipid vesicles (10% PS: 90% PC) also stimulated efflux, while vesicles containing PC alone did not (see below).
This PS-dependent efflux response was not unique to murine J774 macrophage cells, since human blood monocyte-derived macrophages, generated from two different healthy individuals, showed a similar cholesterol efflux in response to apoptotic cells. Moreover, these primary macrophages had similar enhanced efflux response to surrogate apoptotic targets and PS bubbles, but not to necrotic cells ( Figure 2B ). Since PS is also exposed on necrotic cells, but the necrotic cells do not induce an enhanced efflux response from macrophages, either PS exposed on necrotic cells fail to stimulate PS-recognizing receptors on phagocytes or the necrotic cells may stimulate additional receptors that counter the enhanced efflux. Intriguingly, simultaneous addition of PS bubbles or surrogate apoptotic targets with necrotic cells did stimulate an enhanced efflux Figure 1B . In some cases, after the initial incubation with apoptotic cells or necrotic cells and washing away unengulfed targets, the PS bubbles were added and then the efflux response was measured. Each experimental condition was performed in quadruplicate, and mean (6SD) from a representative experiment out of three independent experiments is shown. Asterisk indicates significant difference compared to control. (B) Monocyte-derived macrophages (MDM) from two different normo-lipidemic control subjects were isolated and cultured as previously described [25] . An efflux assay on these macrophages was performed after addition of apoptotic Jurkat cells, necrotic Jurkat cells, surrogate beads, PS bubbles, AJ followed by PS bubbles, and NJ followed by PS bubbles. Each individual experimental condition was performed in quadruplicate and the efflux displayed as mean (6SD) from two independent normo-lipidemic subjects. Asterisk indicates significant difference compared to control. (C) Receptor associated protein (RAP) inhibits enhanced cholesterol efflux induced by apoptotic targets. AJ or surrogate targets were incubated with J774 macrophages or LR73 CHO cells in the presence or absence of the LRP1 ligand and competitive inhibitor RAP (10 mg). After 4 hr, apoA-I specific 3 H-cholesterol efflux was calculated as above. Each individual experimental condition was performed in triplicate and displayed as mean (6SD), and a representative experiment (out of three independent experiments) is presented here. from primary macrophages or J774 cells (Figures 2A and  2B and Figure S2 ). This suggested that necrotic cells perhaps fail to stimulate appropriate engulfment receptors to mediate the enhanced cholesterol efflux. Taken together, these data suggest that engagement of PSrecognizing receptors on phagocytes can stimulate cholesterol efflux from murine and human macrophages.
Potential Role of LRP1 in Regulating Cholesterol
Efflux by Apoptotic Targets At present, multiple phagocyte engulfment receptors and bridging molecules have been linked to recognition of PS on apoptotic cells [1, 2] . A recent report suggested a model that PS on the apoptotic cell surfaces is colocalized with the protein Calreticulin and that they cooperatively provide ligands that stimulate engulfment [7] . Calreticulin on apoptotic cell surfaces is recognized by the low-density lipoprotein receptor-related protein 1 (LRP-1) [7, 11] . LRP1 has also been independently linked to cholesterol regulation and atherosclerosis in humans and mice [12, 13] and is a candidate homolog of the C. elegans engulfment gene CED-1 [14] . We tested whether LRP1 might play a role in regulating cholesterol efflux induced by apoptotic cells. Receptor-associated protein (RAP) is a ligand for LRP1, and addition of soluble RAP can inhibit engulfment of apoptotic cells [7] . Addition of RAP inhibited the enhanced efflux in J774 macrophages and LR73 fibroblasts induced by apoptotic Jurkat cells and surrogate apoptotic targets ( Figure 2C ). This correlated with the ability of RAP to inhibit apoptotic cell uptake ( Figure S3 ). Since a soluble LRP1 ligand a2-macroglobulin did not stimulate efflux from these cells (data not shown), signaling via LRP1 alone might not be sufficient for the enhanced efflux, but rather LRP1 along with other receptor(s) potentially mediates recognition of apoptotic cell surfaces necessary to trigger an enhanced cholesterol efflux.
Upregulation of ABCA1 within Macrophages by Apoptotic Cell Recognition
We then addressed the mechanism by which apoptotic cells may induce increased cholesterol efflux from phagocytes. ABCA1 mediates apoA-I-dependent cholesterol efflux, and loss of ABCA1 in humans leads to Tangier disease, a disorder characterized by very low plasma HDL levels [4] . ABCA1 is also linked to apoptotic cell clearance in mammals [3] , although the precise function of ABCA1 during engulfment remains unclear [15] . We examined the requirement of ABCA1 in cholesterol efflux induced by apoptotic targets by using primary bone marrow-derived macrophages (BMDM) generated from ABCA1-deficient mice [16] . While addition of apoptotic targets enhanced the basal cholesterol efflux in BMDM obtained from wild-type mice, ABCA1 2/2 BMDM efflux showed no enhanced efflux after addition of apoptotic targets ( Figure 3A) . It is noteworthy that under these conditions, there was no significant increase in HDL-dependent efflux (e.g., via ABCG1) (data not shown). Thus, ABCA1 protein was essential for the enhanced cholesterol efflux induced by apoptotic targets.
We then tested whether mRNA and protein levels of ABCA1 in the phagocytes are modified by apoptotic cells, since ABCA1 protein level can be regulated by alteration of cholesterol levels in macrophages [17] .
Real-time PCR showed an increase in abca1 message in J774 cells at 4 and 6 hr after addition of apoptotic cells, compared to necrotic cells ( Figures 3B and 3C) . Consistent with this observation, ABCA1 protein level was also increased by 4 hr after incubation with the apoptotic cells and continued to increase up to 6 hr, with a decrease by 10 hr (Figure 3D and data not shown) . This increase in ABCA1 protein level in J774 cells induced by apoptotic cells was inhibited by addition of Annexin V, suggesting an important role for PS-dependent recognition in the upregulation of ABCA1 protein levels in the macrophages ( Figure 3E) . Moreover, the ABCA1 protein level was not increased by addition of necrotic cells, or anti-CD3-coated apoptotic cells, and correlated with their failure to promote phagocyte cholesterol efflux ( Figure 3E) . Interestingly, addition of 2 mm carboxylate-modified beads also enhanced the ABCA1 protein levels in phagocytes ( Figure 3E ), which correlated with the ability of these beads to stimulate cholesterol efflux. Thus, while the previous studies have suggested that cellular sensing of higher intracellular free cholesterol and oxysterol ligands is important in regulating ABCA1 levels [17, 18] , the above data suggest that signaling downstream of engulfment receptors could also regulate ABCA1 levels and thereby regulate cholesterol efflux.
Role of Nuclear Receptors in Regulating Apoptotic
Cell-Induced ABCA1 Expression Previous studies have suggested a key role for the nuclear receptors PPARg and Liver X receptor (LXR) in transcriptional regulation of cellular ABCA1 levels by oxysterols and the subsequent ABCA1-dependent cholesterol transport from cells [5] . There are at least two pathways by which ABCA1 expression may be regulated by LXR: either a direct activation of LXR by oxysterols or the activation of PPARg receptors that in turn regulate LXR to promote ABCA1 expression. LXRa/b expression is readily detected in J774 cells, while PPARg expression has been variably detected [19, 20] . To test whether the nuclear receptors PPARg and/or LXRa/b might play a role in apoptotic cellinduced upregulation of ABCA1 levels, we used previously characterized antagonists of PPARg and LXR that have been shown to inhibit signaling via these nuclear receptors [18, 21] . Addition of the LXRa/b antagonist geranylgeraniol (denoted GG) stunted the cholesterol efflux from macrophages induced by apoptotic cells. Addition of the PPARg antagonist GW9662 also inhibited the induction of cholesterol efflux stimulated by apoptotic cells (Figure 4A ), and the inhibition was dose dependent ( Figure S4 ). It is notable that the macrophages showed no defects in viability after the drug treatments. This inhibition of cholesterol efflux by the PPARg and LXR antagonist drugs correlated with their ability to inhibit the upregulation of ABCA1 protein by apoptotic cells (Figure 4A ). The PPARg and LXRa/b antagonists also inhibited the increased cholesterol efflux stimulated by PS vesicles, suggesting that PSdependent engulfment signals that promote increased cholesterol efflux require the functional activity of the PPARg and LXR nuclear receptors ( Figure 4B ). Under the same conditions, the addition of PPARg agonist rosiglitizone, or the LXR agonists TO901317 or 22(R)-hydroxycholesterol, stimulated ABCA1 expression consistent with previously published reports (data not shown) [17] . Taken together, these data suggested that the increased ABCA1 expression induced by PS-dependent recognition of apoptotic cells and the increase cholesterol efflux likely involve the nuclear receptors LXR and PPARg that have been previously linked to regulation of ABCA1 expression under other conditions. It is unclear how the engulfment receptors communicate with the nuclear receptors. Although cholesterol loading of cells or entry of oxysterols into the macrophages induce ABCA1 upregulation and efflux [5, 17] , the ability of surrogate apoptotic targets with no cholesterol on their own to stimulate ABCA1 expression suggests that signals from the engulfment receptors leading to PPARg/LXR activation might be more complex, and perhaps novel.
A recent report described a model system of freecholesterol loading of macrophages to make them apoptotic (denoted FC-AM) [22] . By using FC-AM as targets, the authors were able to show an enhancement of cholesterol efflux from other macrophages, through a TNFa-mediated NF-kB-dependent mechanism. Since other reports have shown that TNF and NF-kB inhibit ABCA1 expression [23] , and apoptotic cells can actively suppress TNFa production in the phagocyte [24] , whether FC-AM might use different modalities remain to be determined.
Our observations may also have relevance for the role of macrophages in late-stage atherosclerotic lesions, which contain apoptotic cells and a core of necrotic cells [6] . The uptake of these necrotic cells and the failure to stimulate efflux by the engulfing ''healthy'' macrophages could potentially perpetuate the situation and promote the appearance of cholesterol-laden macrophages (''foam cells''). Interestingly, the addition of artificial targets that mimic apoptotic cells or PS microbubbles were able to stimulate cholesterol efflux when added with necrotic cells (Figures 2A and 2B and Figure S2 ). Thus, triggering of specific engulfment receptors in a physiological way to stimulate efflux from phagocytes might provide a potential therapeutic alternative in the future treatment of atherosclerosis.
In summary, these data reveal several features of a homeostatic program triggered in phagocytes during engulfment, including a proximal signaling event initiated by recognition of PS on apoptotic cells, a downstream signaling event acting through nuclear receptors, and an effector arm involving upregulation of the membrane transporter ABCA1, in turn promoting cholesterol efflux from the phagocytes. These data have important implications for how a phagocyte might maintain homeostasis in the face of incoming lipids and cholesterol derived from the apoptotic cells and for disease states such as atherosclerosis. (A) J774 cells were preincubated with a PPARg antagonist GW9662 (10 mM), PPARg agonist rosiglitizone (100 nM), and LXRa/bantagonist geranylgeraniol (GG) (10 mM) for 16 hr. Apoptotic Jurkat cells were added in the absence or presence of the above drugs, unbound targets were washed, and apoA1-dependent cholesterol efflux was measured as indicated. Each individual experimental condition was performed in quadruplicate and a representative experiment out of three independent experiments is presented here. Asterisk indicates statistically significant change compared to NJ condition. A western blot of ABCA1 protein from the samples numbered according to the treatment conditions above is also shown. Stripping and reprobing of the membrane for Calnexin was used to confirm comparable protein loading. A representative blot out of two independent experiments is presented here. (B) The experiment similar to the above was performed with PS vesicles or PC vesicles, and the cholesterol efflux by J774 cells was measured. Each individual experimental condition was performed in quadruplicate and a representative experiment out of three independent experiments is presented here. Asterisk denotes statistically significant change compared to the control condition.
